Venn Therapeutics

Browse this Section...
Home >> Tags >> Venn Therapeutics

Promising New Cancer Therapy developed via Michigan State University and Venn Therapeutics Partnership

Michigan State University (MSU) researchers presented promising cancer therapy results at the American Association for Cancer Research (AACR) International Meeting in Washington, DC. This novel technology, AdVCA0848, activates the stimulator of interferon genes (STING) pathway to delay tumor growth in a B16 melanoma model, promoting beneficial anti-tumor responses.